Cerence (CRNC) traded down -0.24 % during a 24 hours period ending at 09:39 PM Central Europe on Tuesday 27th. One Cerence stock can currently be bought for about USD 8.47 on popular exchanges. Current supply of Cerence stocks is 46 mn. Cerence has a current market capitalization of USD 375.4 mn and approximately USD 3.3 mn worth of Cerence was traded on exchanges in the last 24 hours. Since last month end, Cerence has traded 6.67 % up. Simple moving average of last 200 days is at USD 9.05. The highest price of past 52 weeks was recorded at USD 13.28 on 05/29/2026. 52 weeks low was at USD 5.85 on 03/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Caleres (CAL) traded down -0.23 % and now trades at USD 12.92. Caleres has a market capitalisation of USD 446.8 mn. Current price/earnings ratio for Caleres is 8.41.

  • Regenxbio (RGNX) traded down -1.5 % and now trades at USD 6.58. Regenxbio has a market capitalisation of USD 446.9 mn.

  • United States Antimony (UAMY) traded down -6.86 % and now trades at USD 3.28. United States Antimony has a market capitalisation of USD 448.3 mn. United States Antimony Corporation announced the completion of a new technical report detailing the antimony‑gold resources on its Nolan Creek property in northern Alaska. The report, prepared by qualified geologist Thomas K. Bundtzen, evaluates measured, indicated and inferred resources, and outlines plans for underground exploration and potential production using long‑hole mining methods. The company, which acquired the claims in a public auction earlier in the year, has begun operating a third‑party mining contractor to extract a bulk sample that will be processed at its Montana facility. The update also notes that the company has secured additional state‑level claims to protect the area following federal‑to‑state land transfers. The filing was submitted to the SEC under Form 8‑K and includes the technical report as an exhibit.

  • Faeth Therapeutics (FTH) traded down -1.46 % and now trades at USD 19.01. Current market capitalisation for Faeth Therapeutics is USD 450.1 mn.

  • Hamilton Beach Brand (HBB) traded up 0.12 % and now trades at USD 32.24. Current market capitalisation for Hamilton Beach Brand is USD 444.8 mn. Hamilton Beach Brand has a current price to earnings ratio of 7.69.

About Cerence

Cerence Inc. is a software development company that specializes in roadmap mobility applications, serving customers globally.